| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0086 | 0.8 |